SCHEMBL379

SCHEMBL379

COc1ccccc1N1CCNCC1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HTR3A P46098 4/20 1.00
DRD2 P14416 3/20 1.00
DRD3 P35462 2/20 1.00
HTR3E A5X5Y0 2/20 1.00
HTR3B O95264 2/20 1.00
HTR3D Q70Z44 2/20 1.00
HTR3C Q8WXA8 2/20 1.00
ADRB1 P08588 2/20 1.00
CYP2C19 P33261 1/20 1.00
HTR6 P50406 1/20 1.00
SIGMAR1 Q99720 1/20 1.00
LMNA P02545 1/20 0.96
MAPT P10636 1/20 0.96
HTR7 P34969 3/20 0.76
HTR1A P08908 5/20 0.68
SLC6A2 P23975 3/20 0.65
SLC6A4 P31645 3/20 0.65
SLC6A3 Q01959 3/20 0.65
HTR2B P41595 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29396943 1.00 HTR3A (1.00) HTR3ADRD2DRD3HTR3EHTR3B
SCHEMBL6366499 1.00 HTR3A (1.00) HTR3ADRD2DRD3HTR3EHTR3B
Bromide SCHEMBL27797305 0.98 HTR3A (0.96) HTR3ADRD2DRD3HTR3EHTR3B
Hydrochloric Acid SCHEMBL246416 0.98 LMNA (1.00) HTR3ADRD2DRD3HTR3EHTR3B
Piperazine SCHEMBL28843777 0.98 HTR3A (0.96) HTR3ADRD2DRD3HTR3EHTR3B
Hydrochloric Acid SCHEMBL29397565 0.98 LMNA (1.00) HTR3ADRD2DRD3HTR3EHTR3B
Hydrochloric Acid SCHEMBL6602545 0.98 LMNA (1.00) HTR3ADRD2DRD3HTR3EHTR3B
Hydrochloric Acid SCHEMBL9069817 0.96 HTR3A (0.93) HTR3ADRD2DRD3HTR3EHTR3B
Iodide SCHEMBL27505006 0.96 HTR3A (0.93) HTR3ADRD2DRD3HTR3EHTR3B
Alcohol SCHEMBL7289118 0.93 DRD2 (0.87) HTR3ADRD2DRD3HTR3EHTR3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2954 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118125995-A Synthesis method of 1- (2-methoxyphenyl) piperazine hydrochloride 南昌大学抚州医学院 2024-06-04 CN claimed
CN-115108999-B Phenyl piperazine quinazoline compound or pharmaceutically acceptable salt thereof, preparation method and application 暨南大学 2023-11-03 CN claimed
CN-114163402-B Industrial preparation method of 3- [4- (2-methoxyphenyl) piperazine-1-yl ] propionitrile 河北一品生物医药有限公司 2023-08-04 CN claimed
US-20230150924-A1 NOVEL COMPOUND HAVING CANCER METASTASIS INHIBITORY ACTIVITY, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION FOR INHIBITING CANCER METASTASIS AND INVASION OR TREATING COLORECTAL CANCER, COMPRISING COMPOUND CELLGENTEK CO., LTD. (KR) 2023-05-18 US claimed
CN-114644838-B Method for preparing black phosphorus-piperazine compound composite material 山东玥能新材料科技有限公司 2023-04-11 CN claimed
CN-112010822-B Method for preparing chiral gamma-amino alcohol and chiral alpha-allyl alcohol by one-pot method 南方科技大学 2022-11-18 CN claimed
CN-115108999-A Phenyl piperazine quinazoline compound or pharmaceutically acceptable salt thereof, preparation method and application 暨南大学 2022-09-27 CN claimed
CN-114920704-A Phenyl piperazine quinazoline compound or pharmaceutically acceptable salt thereof, preparation method and application 暨南大学 2022-08-19 CN claimed
CN-114685399-A Preparation method of urapidil intermediate 1- (2-methoxyphenyl) piperazine and salt thereof 河北广祥制药有限公司 2022-07-01 CN claimed
EP-4019495-A1 NOVEL COMPOUND HAVING CANCER METASTASIS INHIBITORY ACTIVITY, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION FOR INHIBITING CANCER METASTASIS AND INVASION OR TREATING COLORECTAL CANCER, COMPRISING COMPOUND Cellgentek Co., Ltd (KR) 2022-06-29 EP claimed
EP-0120558-B1 ANTIHYPERTENSIVE N-PIPERAZINYLALKANOYLANILIDES RECORDATI S.A. CHEMICAL and PHARMACEUTICAL COMPANY (CH) 1989-03-08 EP claimed
EP-0272478-A1 Glycyrrhetic acid derivatives and use thereof SANWA KAGAKU KENKYUSHO CO., LTD. (JP) 1988-06-29 EP claimed
EP-0251194-A1 Use of carbocyclic and heterocyclic condensed dihydropyridines for the preparation of cardioprotective remedies and heterocyclic and carbocyclic condensed dihydropyridines and methods and intermediates for their preparation BOEHRINGER INGELHEIM KG (DE) 1988-01-07 EP claimed
EP-0089065-B1 NOVEL PHENYLPIPERAZINE DERIVATIVES AND PROCESS FOR PRODUCING THE SAME Chugai Seiyaku Kabushiki Kaisha (JP) 1987-06-16 EP claimed
EP-0120558-A1 Antihypertensive N-piperazinylalkanoylanilides RECORDATI S.A. CHEMICAL and PHARMACEUTICAL COMPANY (CH) 1984-10-03 EP claimed
EP-0089065-A2 Novel phenylpiperazine derivatives and process for producing the same Chugai Seiyaku Kabushiki Kaisha (JP) 1983-09-21 EP claimed
EP-0009655-B1 6-AMINO SUBSTITUTED N-PYRROLYL-3-PYRIDAZINE AMINES, THEIR PREPARATION, AND PHARMACEUTICALLY ANTIHYPERTENSIVE COMPOSITIONS CONTAINING THEM GRUPPO LEPETIT S.P.A. (IT) 1983-05-11 EP claimed
US-4247551-A N-Pyrrolyl-pyridazineamines and their use as antihypertensive agents GRUPPO LEPETIT S.P.A. (IT) 1981-01-27 US claimed
EP-0009655-A1 6-Amino substituted N-pyrrolyl-3-pyridazine amines, their preparation, and pharmaceutically antihypertensive compositions containing them GRUPPO LEPETIT S.P.A. (IT) 1980-04-16 EP claimed
US-3933803-A ANTIBACTERIAL, ANTIMITOTIC, ANTIMYCOTIC INSTITUTO LUSO FARMACO D'ITALIA S.R.L. (IT) 1976-01-20 US claimed